Artificial Cells, Blood Substitutes, and Biotechnology

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Artificial Cells, Blood Substitutes, and Biotechnology  
ABB
Discipline Biochemistry/Biotechnology
Language English
Edited by Thomas M.S. Change, O.C. M.D., C.M., Ph.D., FRCP(C), FRS(C)
Publication details
Publisher
Informa Healthcare (UK)
Publication history
1973–present
Frequency 8 issues per year
no
Indexing
ISSN 1532-4184 (print)
1073-1199 (web)
Links

Artificial Cells, Blood Substitutes, and Biotechnology is an academic journal that publishes review articles on the development of artificial cells, tissue engineering, artificial organs, blood substittues, cell therapy, gene and drug delivery systems, bioencapsulation nanosensors, nanodevices and other areas of biotechnology. It is published by Informa Healthcare.

Core Areas[edit]

  • Tissues and organs
  • Artificial cells
  • Molecules
  • Blood substitutes
  • Tissue engineering
  • Stem cells
  • Gene therapy
  • Drug delivery

Editor-in-Chief[edit]

Thomas M.S. Chang, O.C., M.D., C.M., Ph.D., FRCP(C), FRS(C) is the Editor-in-Chief of Artificial Cells,

Blood Substitutes, and Biotechnology.[1]

Publication Format[edit]

Artificial Cells, Blood Substitutes, and Biotechnology publishes 8 issues per year in simultaneous print and online editions.

References[edit]

  1. ^ "Editorial Board Members". informhealthcare.com. Retrieved 2009-09-16. 

External links[edit]